iRhythm Technologies, Inc. is a healthcare company based in the United States that specializes in digital health solutions for diagnosing cardiac arrhythmias. They offer ambulatory cardiac monitoring services through their innovative Zio platform, which utilizes wearable biosensing technology and advanced data analytics powered by machine learning. With an ESG score of 27.8, iRhythm Technologies is considered a medium-risk investment. This company is reshaping the healthcare industry by providing cutting-edge solutions for improving patient outcomes.